Daiwa Securities Group Inc. Raises Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Daiwa Securities Group Inc. increased its position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 10.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,205 shares of the medical instruments supplier's stock after purchasing an additional 472 shares during the quarter. Daiwa Securities Group Inc.'s holdings in Mettler-Toledo International were worth $6,370,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of MTD. Proficio Capital Partners LLC acquired a new stake in shares of Mettler-Toledo International during the fourth quarter worth about $163,216,000. Seilern Investment Management Ltd acquired a new stake in shares of Mettler-Toledo International during the fourth quarter worth about $89,221,000. AustralianSuper Pty Ltd lifted its holdings in shares of Mettler-Toledo International by 3,183.2% during the fourth quarter. AustralianSuper Pty Ltd now owns 71,673 shares of the medical instruments supplier's stock worth $87,705,000 after purchasing an additional 69,490 shares during the period. Canoe Financial LP lifted its holdings in shares of Mettler-Toledo International by 576.5% during the fourth quarter. Canoe Financial LP now owns 55,518 shares of the medical instruments supplier's stock worth $67,936,000 after purchasing an additional 47,311 shares during the period. Finally, Principal Financial Group Inc. lifted its holdings in shares of Mettler-Toledo International by 13.9% during the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier's stock worth $335,977,000 after purchasing an additional 33,456 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Robert W. Baird boosted their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Evercore ISI boosted their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a report on Monday, February 10th. Citigroup decreased their price target on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a "neutral" rating for the company in a report on Tuesday, March 4th. Wells Fargo & Company boosted their price target on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an "equal weight" rating in a report on Monday, February 10th. Finally, Wolfe Research assumed coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a "peer perform" rating for the company. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $1,380.50.

Remove Ads

Insider Buying and Selling

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares of the company's stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gerry Keller sold 600 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the sale, the insider now directly owns 6 shares of the company's stock, valued at $8,108.04. The trade was a 99.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Price Performance

MTD stock opened at $1,216.92 on Thursday. The firm has a market capitalization of $25.45 billion, a P/E ratio of 30.03, a P/E/G ratio of 3.30 and a beta of 1.15. The business's 50-day moving average is $1,295.55 and its two-hundred day moving average is $1,320.34. Mettler-Toledo International Inc. has a 1 year low of $1,142.91 and a 1 year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, analysts expect that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.